InternationalUSRemember you can easily switch between MIP US and MIP International at any time

MIP European Life Sciences Forum 2018

April 24, Le Méridien Piccadilly London


Agenda

 


Download the brochure here


9:00 Registration

9:30 Opening remarks by Michael Loney, managing editor, Managing IP

9:40 Keynote address: Insight from big Pharma: how can IP leaders drive innovations that will bring value to patients and shareholders, changing global views on IP, innovation and access?
Aaron Smethurst , director, intellectual property policy, UCB Pharma

10:00 Responding to the key challenges in life sciences to promote commercial growth

  • Rethinking your European strategy in preparation of Brexit
  • What does Brexit mean for cross-border litigation?
  • The Unified Patent Court – final preparations for 2018
  • Assessing latest trends in preliminary injunctions across Europe

Annemarie Grabrucker, lawyer, European Patent Office (moderator)
Amarjit Purewal , solicitor, Cancer Research Technology 
Francesco Macchetta , director of IP, Bracco 

10:40 Coffee break and networking

11:00 Defending second medical use patents across multijurisdictions

  • Examining the impact of recent litigation: Lyrica
  • To what extent should you be investigating opportunities for new uses of existing medicines?
  • Considerations and tips when choosing where to enforce your second medical use claim
  • Solutions to overcome cross-labelling infringement

Philipp Cepl, partner, DLA Piper 
Beatriz Díaz de Escauriaza
, senior IP counsel, Chemo Pharma

11:40 Patent infringement by equivalents

  • Application of the doctrine of equivalents– what does the judgement mean in practice?
  • What impact will the doctrine have on life sciences companies?
  • Doctrine of equivalence across Europe: analysing different approaches
  • To what extent are we moving towards harmonisation?

Dieter Kuhn , senior patent attorney, DSM
Jody Giesser , senior patent counsel, DSM

12:20 Lunch and networking

13:20 Scope of SPC regulations

  • Identifying and overcoming the challenges of enforcing your SPC’s
  • Applying SPC regulation across different European jurisdictions
  • The need for legal and business certainty - is the regulation still fit for purpose?
  • Case focus: Mylan v Gilead

Marianne Schaffner, partner, Dentons
Fiona Bor, head of IP, Mereo BioPharma 
Campbell Forsyth
, partner, Dentons

14:00 Arrow declarations: beyond biosimilars

  • Application of issues surrounding Arrow declarations
  • To what extent can you receive declarations for the invalidity of pending patents
  • Analysing European approaches to declaratory relief
  • Impact of Supreme Court in Pemetrexed on declaratory relief

Jenny Davies , principal associate, Gowling WLG 
Jason Rutt
, patent attorney, Boult Wade Tennant

14:40 Coffee break and networking

15:00 Recent approaches to pharma litigation in Russia

  • Preparing your IP litigation strategy: who can be sued and for what? Novartis v Nativa
  • Patent linkage: does it work in Russia?
  • Challenging PTE: a counter-measure of infringers- Pfizer v Canonpharma
  • Compulsory license: a new defense against infringement actions

Natalia Nikolaeva , partner, Gorodissky

15:30 Digital era and evolution of life sciences

  • Adapting your strategy for today’s competitive pharmaceutical market
  • Protecting and developing your assets in a digital world
  • Implications of AI and how it is being used to advance drug treatments
  • Collaborating with outside counsel to manage uncertainty and prepare for changes ahead

Rachel Wallis, partner, Greaves Brewster (moderator)
Axel Ferrazzini , managing director, 4ip Council
Chris Wright, invention developer, Iprova

16:10 Close of conference
 


Sponsors

  Dentons

DLA Piper

Gorodissky

GowlingWLG

Supporting Organisations

AIPPI

glg

IEEPI

PharmaVoice 4ip

More from the Managing IP blog


null null null

null null null


November / December 2019

IP law: are the pressures taking their toll?

Following World Mental Health Day, Max Walters seeks the views of in-house professionals on whether they struggle with workplace pressures, and asks how to improve wellbeing



Most read articles

Supplements